Old CML Drug Makes Comeback

(00:04:18) Elsevier Global Medical News, 2009 Dec 7, JS MacNeil

Dr. Jorge Cortes is Professor of Medicine at the University of Texas M.D. Anderson Cancer Center in Houston.

Omacetaxine mepesuccinate, an old drug with a new name, is making a comeback as a potential therapy for chronic myeloid leukemia with the T315I mutation that has proved resistant to imatinib and other tyrosine kinase inhibitors. 

See related videos to:
ASH 2009

Related Link:

News Article: CML Drug Makes Comeback as Treatment for Imatinib-Resistant Mutations »

Copyright © 2010 International Medical News Group
Subscribe Now »